Population pharmacokinetics and exposure–response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection - Concepedia

Concepedia

Publication | Open Access

Population pharmacokinetics and exposure–response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection

DOI Full Paper Access

17

Citations

18

References

2016

Year

Anubha Gupta, Ziad Hussein, Raffit Hassan, Jason Wustner, Julia D. Maltzman, Bruce A. Wallin

Cancer Chemotherapy and Pharmacology

MedicineMetronomic TherapyImmunologyDose SelectionPharmacotherapyPopulation PharmacokineticsImmunotherapyOncologyAnti-mesothelin Monoclonal Antibody

References

	Year	Citations

Page 1